Previous close | 86.45 |
Open | 87.20 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 800 |
Day's range | 85.38 - 87.06 |
52-week range | 60.57 - 96.12 |
Volume | |
Avg. volume | 4,026,537 |
Market cap | 51.615B |
Beta (5Y monthly) | 1.07 |
PE ratio (TTM) | 37.28 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
Molina's (MOH) first-quarter performance is likely to have been hurt by escalating medical care costs, partly offset by growing membership in all three businesses.